Hopemark Health delivers integrated outpatient psychiatric care through a multidisciplinary team of psychiatrists, therapists, psychiatric nurse practitioners, physician assistants, and support staff. Founded in 2016 by Dr. Abid Nazeer, the company operates multiple clinics in the greater Chicago area and has completed thousands of treatments for patients with mental health and substance use disorders. Hopemark is noted for its work in ketamine-based therapies and evidence-based treatment programs. The company’s recent minority investment from BrainsWay provides growth capital and an operational partnership to help scale clinic access. Hopemark’s clinical operations are positioned to expand access to interventional psychiatry modalities alongside its existing services.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

May 2026